Sinocelltech Group Limited (SHSE: 688520)
Health Care · Biotechnology · CN
CN¥37.89
-3.83% today · -44.7% 1Y
Sinocelltech Group Limited (SHSE: 688520) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.65B and employs 2,200 people.
Over the last twelve months the share price has lost 44.7%, trading between 31.35 and 70.50.
Tweenvest scores Sinocelltech Group Limited across four factors: quality 31/100, value 63/100, growth 100/100. Its strongest factor is growth.
688520 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.65B
- Revenue (TTM)
- $197.70M
- P/E
- —
- EPS
- -1.95
- Dividend yield
- —
- Beta (5Y)
- 0.73
- 52-week high
- CN¥70.50
- 52-week low
- CN¥31.35
- Avg volume (3M)
- —
- Shares outstanding
- 470.34M
- Employees
- 2,200
- Next earnings
- —
About Sinocelltech Group Limited
Sinocelltech Group Limited is a Beijing-based biotechnology enterprise. The company's primary focus lies in pioneering and refining the technologies required for both the creation and large-scale production of vital biological agents, specifically recombinant proteins, monoclonal antibodies, and vaccines, throughout China.
- Founded
- 2007
- Listed since
- Jun 22, 2020
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $263.82 | -0.43% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $440.91 | +0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $145.58 | -0.37% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $547.48 | -0.10% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $826.60 | -0.89% |
| argenx SEENXTBR: ARGX | $65.85B | €877.40 | -2.73% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $133.27 | -8.13% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.